Moreover, the IL6/JAK/STAT3 pathway has been found to upregulate CXCL1, CXCL2, CXCL3, and CXCL11 in patients with colon cancer, which was associated with prognosis [1]. Here, CXCL1 is linked to malignant colon neoplasm.